Addressing the unmet promise of antidepressant trials in older adults

Primary Psychiatry

Volumn 13, Issue 2, 2006, Pages

  Kennedy, Gary J ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c MMC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PROTOCOL; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; EVALUATION; HAMILTON SCALE; HEALTH CARE DELIVERY; HUMAN; HYPONATREMIA; MEDICAL SOCIETY; MENTAL HEALTH SERVICE; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PATIENT MONITORING; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REMISSION; RESEARCH ETHICS; REVIEW; SYMPTOM;

EID: 33644553072     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Eng J Med. 2005;352(24):2515-2523.
2. Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United Sates, 1990-1992 to 2001-2003. JAMA. 2005;293(20):2487-2495.
3. Priorities for Prevention Research at NIMH: A report by the National Advisory Mental Health Council Workgroup on mental disorders prevention research. National Institute of Mental Health, National Institutes of Health. 1998; NIH Publication 98-4321. Available at: http://www.nimh.nih.gov/publicat/ nimhpriorrpt.pdf. Accessed November 30, 2005.
4. Mamdani MM, Parikh SV, Austin PC, et al. Use of antidepressants among elderly subjects: trends and contributing factors. Am J Psychiatry. 2000;157(3):360-367.
5. Kennedy GJ. New drugs for old folks: the evidence based argument for the newer antidepressants. J Am Geriatr Soc. 2001;49(2):227-228.
6. Kennedy GJ. The geriatric syndrome of late-life depression. Psychiatr Serv. 1995;46(1):43-48.
7. Kennedy GJ, Kelman HR, Thomas C. Persistence and remission of depressive symptoms in late life. Am J Psychiatry. 1991;148(2):174-178.
8. Williams JW, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132(9):743-756.
9. Shasha M, Lyons JS, O'Mahoney MT, Rosenberg A, Miller Si, Howard KI. Serotonin reuptake inhibitors and the adequacy of antidepressant treatment. Int J Psychiatry Med. 1997;27(2):83-92.
10. Ünutzer J, Simon G, Belin TR, Datt M, Katon W, Patrick D. Care for depression in HMO patients age 65 and older. J Am Geriatr Soc. 2000;48(8):871-878.
11. Lebowitz BD, Pearson IL, Schneider LS, et al. Diagnosis and treatment of depression in later life. Consensus statement update. JAMA. 1997;278(14):1186- 1190.
12. NCQA Health Plans Employer Data and Information Set. Available at: http://www.ncqa.org/communications/publications/hedispub.htm. Accessed November 30, 2005.
13. Lavori PW. Improving treatment of depression in the elderly: two innovations in statistical design of clinical trials. J Clin Psychopharmacol. 2005;25(4 suppl 1):S38-S44.
14. Pollock BG. The pharmacokinetic imperative in late-life depression. J Clin Psychopharmacol. 2005;25(4 suppl 1):S19-S23.
15. Krishnan KRR. Treatment of depression in the medically ill. J Clin Psychopharmacol. 2005;25(4 suppl 1):S14-S18.
16. ENRICHD Investigators. Enhancing recovery in coronary heart disease patients (ENRICHD): rationale and design. Psychosom Med 2001;63(5):747-755.
17. Glassman AH, D'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701-709.
18. Erratum in: JAMA. 2002;288(14):1720.
19. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997;59(3):241-250.
20. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized a double blind placebo-controlled trial. Diabetes Care. 2000;23(5):618-623.
21. Roose SP, Schatzberg AF. The efficacy of antidepressants in the treatment of late-life depression. J Clin Psychopharmacol. 2005;25(4 suppl 1):S1-S7.
22. Sackeim HA, Roose SP, Hurt T. Optimal length of antidepressant trials in late-life depression. J Clin Psychopharmacol. 2005;25(4 suppl 1):S34-S37.
23. Kupfer DJ. Achieving adequate outcomes in geriatric depression: standardized criteria for remission. J Clin Psychopharmacol. 2005(4 suppl 1);25:S24-S28.
24. Gildengers AG, Houck PR, Mulsant BH, et al. Trajectories of treatment response in late-life depression: psychosocial and clinical correlates. J Clin Psychopharmacol. 2005;25(4 suppl 1):S8-S13.
25. Whyte EM, Dew MA, Gildengers A, et al. Time course of response to antidepressants in late-life depression: therapeutic implications. Drugs Aging. 2004;21(8):531-554.
26. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial and growing. JAMA. 2002;287(14):1840- 1847.